Volume 193, Issue 4, April 2015, Pages 1382–1387
Investigative Urology
Olfactory System of Highly Trained Dogs Detects Prostate Cancer in Urine Samples
Presented at annual meeting of American Urological Association, Orlando, Florida, May 16-21, 2014.
Purpose
We
established diagnostic accuracy in terms of the sensitivity and
specificity with which a rigorously trained canine olfactory system
could recognize specific volatile organic compounds of prostate cancer
in urine samples.
Materials and Methods
Two
3-year-old female German Shepherd Explosion Detection Dogs were trained
to identify prostate cancer specific volatile organic compounds in
urine samples. They were tested on 362 patients with prostate cancer
(range low risk to metastatic) and on 540 healthy controls with no
nonneoplastic disease or nonprostatic tumor. This cross-sectional design
for diagnostic accuracy was performed at a single Italian teaching
hospital and at the Italian Ministry of Defense Military Veterinary
Center.
Results
For dog 1
sensitivity was 100% (95% CI 99.0–100.0) and specificity was 98.7% (95%
CI 97.3–99.5). For dog 2 sensitivity was 98.6% (95% CI 96.8–99.6) and
specificity was 97.6% (95% CI 95.9–98.7). When considering only men
older than 45 years in the control group, dog 1 achieved 100%
sensitivity and 98% specificity (95% CI 96–99.2), and dog 2 achieved
98.6% sensitivity (95% CI 96.8–99.6) and 96.4% specificity (95% CI
93.9–98.1). Analysis of false-positive cases revealed no consistent
pattern in participant demographics or tumor characteristics.
Conclusions
A
trained canine olfactory system can detect prostate cancer specific
volatile organic compounds in urine samples with high estimated
sensitivity and specificity. Further studies are needed to investigate
the potential predictive value of this procedure to identify prostate
cancer.
Key Words
- prostatic neoplasms;
- diagnosis;
- dogs;
- olfactory perception;
- volatile organic compounds
Abbreviations and Acronyms
- DRE, digital rectal examination;
- LR, likelihood ratio;
- PC, prostate cancer;
- PSA, prostate specific antigen;
- TURP, transurethral prostate resection;
- VOC, volatile organic compound
Prostate cancer represents the fifth most frequent cancer in the world.1
Although PSA testing has increased PC detection, the main drawback is
its lack of specificity and accuracy. High serum PSA levels can be
detected in men with nonmalignant conditions.2 Therefore, many men with increased PSA values undergo biopsy sampling,3, 4 and 5
although this procedure is invasive, offers a low level of accuracy (ie
only 30% detection rate at the first biopsy) and is prone to various
complications, including sepsis and death.6 and 7 Consequently there is a need for a more sensitive diagnostic method.3
Dogs are used for detecting explosives and drugs through their
olfactory system, which can perceive thresholds as low as parts per
trillion.8 As outlined in 1971 by Pauling et al9 and in 2012 by Lippi and Cervellin10
VOCs can be identified in human urine samples. Several studies have
shown that dogs may be trained to identify patients with cancer by
tracing the presence of a unique odor signature.
In 1989 Williams and Pembroke provided the first evidence on sniffer dogs.11
In 2001 Church and Williams reported on a 66-year-old man in whom a
patch of eczema developed at which a pet Labrador persistently sniffed.12 Histopathology revealed basal cell carcinoma. Since 2001, groups have reported the detection of bladder,13, 14 and 15 lung and breast,16 skin17 and ovarian18 and 19 cancers, and infectious diseases20 using the canine sense of smell.
Gordon21 and Cornu22
et al extended the use of detection dogs to PC. Although Gordon et al
did not report positive results, they pointed out procedural errors that
needed to be addressed by later researchers.21
They concluded that the study was unfortunately not successful but it
provided lessons in the form of mistakes, which were presented in the
hope that others might benefit from them. On the other hand, Cornu et al
noted 91% sensitivity and specificity.22 Cornu et al took a step forward from Gordon et al,21 although they acknowledged important biases.22
A limited series of patients was enrolled, only 1 dog was used and the
control group included patients older than 50 years with PSA greater
than 8 ng/ml who were at high risk for undetected PC.
The
opinion of Lippi and Cervellin that the most problematic issue has been
the heterogeneity of performance among studies as well as in the
same study10
together with the limited patient cohorts and nonstandardized training
methodologies led us to design an accurate procedure to investigate
whether dog olfactory detection remains a myth or could become a real
clinical opportunity. We assessed diagnostic accuracy in terms of the
sensitivity and specificity at which a rigorously trained canine
olfactory system could recognize PC specific VOCs in urine in a large
series of patients with PC of different stages and grades vs a
heterogeneous control group.